fda warning bpc 157 not approved drug letter bpc-157 unapproved new The U.S. Food and Drug Administration is moving Is BPC 157 Legal? Understanding

Enhancing clinical evidence by proactively building quality into clinical trials

Chelombitko, M

We utilize small-batch synthesis to ensure that every single vial and every capsule contains a compound of the highest purity and structural integrity

Thus, as opposed to the present discrepancy, there may likely be a relevant resolution with the consistent anti-glaucomatous effect of the pentadecapeptide BPC 157 based on its beneficial cytoprotective effect

doi: 10.1038/ctg.2013.9 [DOI] [PMC free article] [PubMed] [Google Scholar] 224

Again, coverage is only likely when the GLP-1 drug is prescribed for an FDA-approved use